Sirna Therapeutics Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sirna Therapeutics Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Leman who wrote (79)	5/6/1998 1:42:00 PM
From: Baker	Read Replies (1) of 562

Glad to see RZYM getting some mention. Right now there are only two analysts (according to First Call) that follow RZYM. One has a strong buy recommendation and the other a moderate buy recommendation. Of course these were both previous to yesterday's announcement. As a result I would imagine neither would lower their recommendation and the moderate buy may be raised. If RZYM could only get the attention of a few more analysts then we'd probably see a greater stock movement. When RZYM has moved up in the past, it seems to have done so very late in the trading day. Someone jumps in within the last five or ten minutes of the day and the stock gets a jolt. Maybe we'll see the same today. The biggest drawback is that the projections are that RZYM won't have a drug on the market (of any type) until the year 2000. Of course, they have a lot of royalty/benchmark payments from other partners that should help the EPS in the future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next